ALR now trading at a whopping 29% discount to ABT’s $56/sh buyout price, implying that many investors think ABT will find a way to scuttle the deal. Yesterday, ALR agreed to permanently recall an INR point-of-care device that plainly didn’t work.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”